Moderna Inc (NAS:MRNA)
$ 141.01 8.11 (6.1%) Market Cap: 54.04 Bil Enterprise Value: 43.65 Bil PE Ratio: 0 PB Ratio: 4.21 GF Score: 68/100

Moderna Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 01:30PM GMT
Release Date Price: $23.61 (+5.68%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Hi, everyone. My name is Gena Wang. I'm a mid-cap biotech analyst at the Barclays. I first hope everyone stay healthy, and I would like to thank all the participants, investors, companies and especially our event team and corporate access team, who made this virtual health care conference possible.

With that, I would like to introduce our next speaker, Tal Zaks, Chief Medical Officer from Moderna. Tal, I'll hand over to you.

Tal Zaks
Moderna, Inc. - Chief Medical Officer

Thank you, and welcome, everybody, to our webcast. I hope you're sitting next to a fireside -- I was promised this would be a fireside chat. So we'll do it virtual.

Slide 2 is our forward-looking statement, which is basically the Moderna's interpretation of an old Biblical saying that, in modern times prophecy has been given to fools. So to the degree I'm making forward-looking statements, please note that.

On Slide 3 is our notion of what mRNA is and why we have been so excited to move this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot